Filing Details

Accession Number:
0001209191-15-065334
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-11 17:40:47
Reporting Period:
2015-08-07
Filing Date:
2015-08-11
Accepted Time:
2015-08-11 17:40:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472187 Edi Hienrich 800 W. Olympic Blvd. Suite 406
Los Angeles CA 90015
Svp/Managing Director Emea No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-07 3,600 $6.82 9,947 No 4 M Direct
Common Stock Disposition 2015-08-07 1,965 $60.00 7,982 No 4 D Direct
Common Stock Disposition 2015-08-07 5,487 $60.00 2,495 No 4 S Direct
Common Stock Disposition 2015-08-10 1,635 $59.89 860 No 4 S Direct
Common Stock Acquisiton 2015-08-07 3,060 $6.82 3,403 No 4 M Indirect By wife
Common Stock Disposition 2015-08-07 1,670 $60.00 1,733 No 4 D Indirect By wife
Common Stock Disposition 2015-08-07 343 $60.00 1,390 No 4 S Indirect By wife
Common Stock Disposition 2015-08-10 1,390 $59.89 0 No 4 S Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 S Direct
No 4 S Direct
No 4 M Indirect By wife
No 4 D Indirect By wife
No 4 S Indirect By wife
No 4 S Indirect By wife
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2015-08-07 3,600 $0.00 3,600 $6.82
Common Stock Stock Appreciation Rights Disposition 2015-08-07 3,060 $0.00 3,060 $6.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-02-27 2019-02-27 No 4 M Direct
0 2012-02-27 2019-02-27 No 4 M Indirect
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2015.
  2. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2015.
  3. These stock appreciation rights were fully vested as of February 27, 2012.